Hauptseite > Publikationsdatenbank > Relaxation behavior study of ultra-small superparamagnetic iron oxide nanoparticles at ultra-low and ultra-high magnetic fields > print

001     18219
005     20240619091001.0
024 7 _ |2 pmid
|a pmid:21972868
024 7 _ |2 DOI
|a 10.1021/jp2066138
024 7 _ |2 WOS
|a WOS:000297608600051
037 _ _ |a PreJuSER-18219
041 _ _ |a eng
082 _ _ |a 530
084 _ _ |2 WoS
|a Chemistry, Physical
100 1 _ |a Wang, W.
|b 0
|u FZJ
|0 P:(DE-Juel1)VDB72696
245 _ _ |a Relaxation behavior study of ultra-small superparamagnetic iron oxide nanoparticles at ultra-low and ultra-high magnetic fields
260 _ _ |a Washington, DC
|b Soc.
|c 2011
300 _ _ |a 14789 - 14793
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |a Journal of Physical Chemistry B
|x 1520-6106
|0 3694
|y 49
|v 115
500 _ _ |a We would like to thank F. Dorn for TEM imaging, J. Bachhausen for IR measurements, and H. Lippert for the ICP-OES measurements. This work is supported by the Research Center Juelich, the China Scholarship Council (CSC), and the German Helmholtz Association.
520 _ _ |a Ultrasmall superparamagnetic iron oxide nanoparticles (USPIOs) have attracted attention because of their current and potential usefulness as contrast agents for magnetic resonance imaging (MRI) and nuclear magnetic resonance (NMR). USPIOs are usually used for their significant capacity to produce predominant proton relaxation effects, which result in signal reduction. However, most previous studies that utilized USPIOs have been focused on the relaxation behavior at commonly used magnetic fields of clinical MRI systems (typically 1-3 T). In this paper, magnetic relaxation processes of protons in water surrounding the USPIOs are studied at ultralow (≤10 mT) and ultrahigh magnetic fields (14.1 T). USPIOs used in our experiments were synthesized with a core size of 6 nm, and transferred from organic to water by ligand exchange. The proton spin-lattice relaxation time (T(1)) and spin-spin relaxation time (T(2)) were investigated at ultralow (212 μT for T(2) and 10 mT for T(1)) and at 14.1 T with different iron concentrations. At all of the fields, there is a linear relationship between the inverse of relaxation times and the iron concentration. The spin-spin relaxivity (r(2)) at 14.1 T is much larger than that value of the ultralow field. At ultralow field, however, the spin-lattice relaxivity (r(1)) is larger than the r(1) at ultrahigh field. The results provide a perspective on potential in vivo and in vitro applications of USPIOs in ultralow and ultrahigh field NMR and MRI.
536 _ _ |a Funktion und Dysfunktion des Nervensystems
|c P33
|2 G:(DE-HGF)
|0 G:(DE-Juel1)FUEK409
|x 0
536 _ _ |a Grundlagen für zukünftige Informationstechnologien
|c P42
|0 G:(DE-Juel1)FUEK412
|x 1
536 _ _ |a BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung
|c P45
|0 G:(DE-Juel1)FUEK505
|x 2
588 _ _ |a Dataset connected to Web of Science, Pubmed
650 _ 2 |2 MeSH
|a Contrast Media: chemistry
650 _ 2 |2 MeSH
|a Ferric Compounds: chemistry
650 _ 2 |2 MeSH
|a Magnetic Fields
650 _ 2 |2 MeSH
|a Magnetite Nanoparticles: chemistry
650 _ 2 |2 MeSH
|a Solubility
650 _ 2 |2 MeSH
|a Water: chemistry
650 _ 7 |0 0
|2 NLM Chemicals
|a Contrast Media
650 _ 7 |0 0
|2 NLM Chemicals
|a Ferric Compounds
650 _ 7 |0 0
|2 NLM Chemicals
|a Magnetite Nanoparticles
650 _ 7 |0 1309-37-1
|2 NLM Chemicals
|a ferric oxide
650 _ 7 |0 7732-18-5
|2 NLM Chemicals
|a Water
650 _ 7 |a J
|2 WoSType
700 1 _ |a Dong, H.
|b 1
|0 P:(DE-HGF)0
700 1 _ |a Pacheco, V.
|b 2
|u FZJ
|0 P:(DE-Juel1)VDB70443
700 1 _ |a Willbold, D.
|b 3
|u FZJ
|0 P:(DE-Juel1)132029
700 1 _ |a Zhang, Y.
|b 4
|u FZJ
|0 P:(DE-Juel1)VDB5476
700 1 _ |a Offenhäusser, A.
|b 5
|0 P:(DE-HGF)0
700 1 _ |a Hartmann, R.
|b 6
|u FZJ
|0 P:(DE-Juel1)VDB57647
700 1 _ |a Weirich, T.
|b 7
|0 P:(DE-HGF)0
700 1 _ |a Ma, P.
|b 8
|u FZJ
|0 P:(DE-Juel1)VDB84828
700 1 _ |a Krause, H. J.
|b 9
|0 P:(DE-HGF)0
700 1 _ |a Gu, Z.
|b 10
|0 P:(DE-HGF)0
773 _ _ |a 10.1021/jp2066138
|g Vol. 115, p. 14789 - 14793
|p 14789 - 14793
|q 115<14789 - 14793
|0 PERI:(DE-600)2006039-7
|t The @journal of physical chemistry / B
|v 115
|y 2011
|x 1520-6106
856 7 _ |u http://dx.doi.org/10.1021/jp2066138
909 C O |o oai:juser.fz-juelich.de:18219
|p VDB
913 1 _ |k P33
|v Funktion und Dysfunktion des Nervensystems
|l Funktion und Dysfunktion des Nervensystems
|b Gesundheit
|0 G:(DE-Juel1)FUEK409
|x 0
913 1 _ |k P42
|v Grundlagen für zukünftige Informationstechnologien
|l Grundlagen für zukünftige Informationstechnologien (FIT)
|b Schlüsseltechnologien
|0 G:(DE-Juel1)FUEK412
|x 1
913 1 _ |k P45
|v BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung
|l Biologische Informationsverarbeitung
|b Schlüsseltechnologien
|0 G:(DE-Juel1)FUEK505
|x 2
913 2 _ |a DE-HGF
|b Key Technologies
|l BioSoft Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-551
|2 G:(DE-HGF)POF3-500
|v Functional Macromolecules and Complexes
|x 0
914 1 _ |y 2011
915 _ _ |0 StatID:(DE-HGF)0010
|a JCR/ISI refereed
920 1 _ |k ICS-6
|l Strukturbiochemie
|g ICS
|0 I:(DE-Juel1)ICS-6-20110106
|x 0
920 1 _ |k PGI-8
|l Bioelektronik
|g PGI
|0 I:(DE-Juel1)PGI-8-20110106
|x 1
920 1 _ |k ICS-8
|l Bioelektronik
|g ICS
|0 I:(DE-Juel1)ICS-8-20110106
|x 2
970 _ _ |a VDB:(DE-Juel1)132871
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
980 _ _ |a I:(DE-Juel1)PGI-8-20110106
980 _ _ |a I:(DE-Juel1)ICS-8-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-7-20200312
981 _ _ |a I:(DE-Juel1)IBI-3-20200312
981 _ _ |a I:(DE-Juel1)PGI-8-20110106
981 _ _ |a I:(DE-Juel1)ICS-8-20110106

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21